Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.71 |
| ▸ | LMNA | P02545 | 9/20 | 0.71 |
| ▸ | HTT | P42858 | 8/20 | 0.71 |
| ▸ | RAB9A | P51151 | 4/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.62 |
| ▸ | NAMPT | P43490 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | GALR3 | O60755 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27083360 | 0.85 | SMN1; SMN2 (0.73) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL3923271 | 0.83 | SMN1; SMN2 (0.71) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL7663045 | 0.83 | SMN1; SMN2 (0.71) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL4662893 | 0.83 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL12090287 | 0.82 | NAMPT (0.60) | SMN1; SMN2LMNAALDH1A1NAMPT | |
| SCHEMBL3571824 | 0.81 | SMN1; SMN2 (0.68) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL27083363 | 0.81 | SMN1; SMN2 (0.82) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL27950177 | 0.80 | CA12 (0.71) | SMN1; SMN2LMNAHTTALDH1A1MAPT | |
| SCHEMBL4402015 | 0.80 | SMN1; SMN2 (0.66) | SMN1; SMN2LMNAHTTRAB9ANPC1 | |
| SCHEMBL5783946 | 0.80 | CYP19A1 (0.79) | SMN1; SMN2LMNAHTTRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014065411-A1 | SULFONAMIDE DERIVATIVE AS HARMFUL-ORGANISM CONTROL AGENT FOR AGRICULTURAL/HORTICULTURAL USE | 株式会社エス・ディー・エス バイオテック (JP) | 2014-05-01 | — | — | WO | disclosed |
| EP-1860941-B1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF SE (DE) | 2008-11-12 | — | — | EP | disclosed |
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | disclosed |
| EP-1860941-A1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006097489-A1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | PTPN21, PTPN1, PTPN14 | SMN1; SMN2 2697/4885LMNA 4054/4885HTT 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.